Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOCRATE: Radiotherapy in Metastatic Gastroesophageal Cancer
NCT06922279Active, not recruiting
- Sponsor
- Policlinico Gemelli
- Start
- Nov 2024
- Primary completion
- Oct 2029
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Policlinico Gemelli. Primary endpoint: Disappearance of symptoms at 12 months. Started Nov 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06922279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06922279.